Skip to main content
Erschienen in: BMC Cancer 1/2019

Open Access 01.12.2019 | Research article

A systematic review: comparative analysis of the effects of propofol and sevoflurane on postoperative cognitive function in elderly patients with lung cancer

verfasst von: Haitao Sun, Guohua Zhang, Bolun Ai, Huimin Zhang, Xiangyi Kong, Wan-Ting Lee, Hui Zheng, Tao Yan, Li Sun

Erschienen in: BMC Cancer | Ausgabe 1/2019

Abstract

Background

The potential risk for cognitive impairment following surgery and anesthesia is a common concern, especially in the elderly and more fragile patients. The risk for various neurocognitive effects is thus an area of importance. The independent impact of surgery and anesthesia is still not known. Likewise, the independent effect of different drugs used during anesthesia is a matter of debate, as is the number and amounts of drugs used and the “depth of anesthesia.” So, understanding the drug-related phenomenon and mechanisms for postoperative cognitive impairment is essential. This meta-analysis aims to compare the effects of propofol and sevoflurane anesthesia on postoperative cognitive function in elderly patients with lung cancer.

Methods

This study is a systematic review and meta-analysis for controlled clinical studies. Public-available online databases were searched to identify eligible randomized placebo-controlled trials or prospective cohort studies concerning the effects of propofol and sevoflurane on postoperative cognitive function. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is the serum S100beta concentration 24 h after surgery. Standard mean differences (SMDs) along with 95% confidence intervals (CIs) were extracted and analyzed using random or fixed-effects models. Analyses regarding heterogeneity, risk of bias assessment, and sensitivity were performed.

Results

We searched 1626 eligible publications and 14 studies of 1404 patients were included in the final analysis. The majority of included studies had been undertaken in Asian populations. Results suggested that propofol has a greater adverse effect on cognitive function in the elderly patients with lung cancer than sevoflurane. There were significant differences in issues of MMSE 6 h (11 studies; SMD -1.391, 95% CI -2.024, − 0.757; p < 0.001), MMSE 24 h (14 studies; SMD -1.106, 95% CI -1.588, − 0.624; p < 0.001), MMSE 3d (11 studies; SMD -1.065, 95% CI -1.564, − 0.566; p < 0.001), MMSE 7d (10 studies; SMD -0.422, 95% CI -0.549, − 0.295; p < 0.001), and serum S100beta concentration at 1 day after surgery (13 studies; SMD 0.746, 95% CI 0.475, 1.017; p < 0.001).

Conclusion

Propofol has a more significant adverse effect on postoperative cognitive function in elderly patients with lung cancer than sevoflurane.
Hinweise
Haitao Sun, Guohua Zhang, Bolun Ai, Huimin Zhang and Xiangyi Kong contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ASA
America Society of Anesthesiologist
CI
Confidence interval
CNKI
China National Knowledge Infrastructure
CNS
Central nervous system
MMSE
Mini-mental state examination
SMD
Standard mean difference

Background

Cognitive impairment is a neurological disorder that occurs in adults, which involves cognitive disorders with impairment in instrumental activities of daily living [1, 2]. Previous studies have shown that about 234 million patients worldwide undergo surgery each year, and about 41% of elderly patients have cognitive impairment after surgery or anesthesia. Thirteen percent of patients still have cognitive impairment 3 months after discharge [3, 4]. Cognitive impairment severely affects the prognosis of patients who have undergone general anesthesia surgeries, especially elderly patients, including decreased quality of life, loss of independence, and increased mortality [5]. Patients with lung cancer frequently encounter postoperative cognitive dysfunction. In elderly patients, severe cognitive impairment is more likely to occur after anesthesia. This may be due to a combination of multiple factors, such as inflammation caused by surgical trauma, infection, opioids, stress, and sleep disorders [6]. Because the incidence of cognitive impairment is positively correlated with the duration of anesthesia, general anesthetic drugs are thought to be one of the causes of cognitive impairment in elderly patients [7].
Worldwide, lung cancer occurred in approximately 1.8 million patients in 2012 and caused an estimated 1.6 million deaths [8]. This is increased from 1.6 million new diagnoses and 1.4 million lung cancer deaths in 2008 [9]. The treatment for early-stage lung cancer is mainly surgical treatment. Propofol and sevoflurane are the most commonly used general anesthetic drugs in clinical practice [10]. However, in terms of causing postoperative cognitive functions, there are still controversies regarding the use of propofol anesthesia or sevoflurane anesthesia in elderly patients with lung cancer. Current published studies on this topic were with relatively smaller sample sizes and were lack of consistency. Therefore, we conducted this systematic review and meta-analysis to derive a pooled estimate of the effects of propofol and sevoflurane on postoperative cognitive functions in patients with lung cancer, with an improved statistical power as compared to individual studies. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoints are serum S100beta concentration 24 h after surgery. S100β is glial-specific and is expressed primarily by astrocytes. It functions in the process of neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis, axonal proliferation, and inhibition of microtubule assembly. In the developing central nervous system (CNS), it acts as a neurotrophic factor and neuronal survival protein. In the adult organism, it is usually elevated due to nervous system damage, which makes it a potential clinical marker. S100β is involved in the regulation of cell shape, cell growth, energy metabolism, cell-to-cell communication, contraction, and intracellular signal transduction. The correlation between serum S100β protein levels and cognitive dysfunction.

Methods

Research protocol overview

Public-available online databases were searched to identify eligible randomized placebo-controlled trials or prospective cohort studies concerning the effects of propofol and sevoflurane on postoperative cognitive function. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is the serum S100beta concentration 24 h after surgery. Standard mean differences (SMDs) along with 95% confidence intervals (CIs) were extracted and analyzed using random or fixed-effects models. Analyses regarding heterogeneity, risk of bias assessment, and sensitivity were performed.

Search strategies

We searched the databases of Embase, Pubmed, The Cochrane Library, Web of Science, and China National Knowledge Infrastructure (CNKI). Retrieval time is from the database construction time to March 2018. The English search words include propofol, sevoflurane, cognitive, and lung cancer. The Chinese search words are the Chinese translation of the above words. There are no language and time limits. For the retrieved documents, we further tracked their references to include the ones that met the inclusion criteria.

Inclusion and exclusion criteria

This study analyzed studies with a population of > 60 years-old, ASA class I to III patients who had scheduled for lung cancer surgeries, and received propofol or sevoflurane during anesthesia. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is serum S100beta concentration 24 h after surgery. Specific inclusion criteria and exclusion criteria were reported in Table 1.
Table 1
Inclusion criteria for study selection in this meta-analysis
Number
Inclusion criteria
1
Original prospective cohort studies or randomized controlled trials (RCTs) published in full text and those for which we had full access to all original data and protocols.
2
The studies evaluated the differences of the effect of propofol and sevoflurane on postoperative cognitive functions.
3
Regarding the intervening measures between different groups, the only difference is that the two groups received propofol or sevoflurane, respectively. Other conditions should be the same.
4
Human studies.
5
Predefined outcomes: incidence of postoperative MMSE scores and the plasma protein S100β at various time points.
6
No minimal sample size or dosing regimen was required for inclusion.
Number
Exclusion criteria
1
The study did not have a control group of patients without propofol use or sevoflurane use.
2
They were case studies or case series.
3
The report focused exclusively on other topics or outcomes.
4
No human data were included.
5
Except for the difference of anaesthetic administration, there were other differences between the experimental groups and the control groups.
6
Reviews and duplicated publications.

Data extraction and quality evaluation

Two researchers independently conducted literature screening and quality evaluation of the obtained documents. In case of disagreement, they would reach an agreement by discussion or invite a third party to adjudicate. Data extraction: 1) necessary information included in the study, such as first author and publication date; 2) general data of patients in the experimental group and control group, such as the sex, age, America Society of Anesthesiologist (ASA) classification, intervention measures, operations, etc.; 3) anesthesia methods, including methods of inducing anesthesia and maintenance of anesthesia, and the drug doses; 4) outcomes, including preoperative and postoperative MMSE scores, changes in serum S100beta concentration before and after surgery. The main characteristics of the included studies were summarized in Table 2.
Table 2
Characteristics of studies included in the meta-analysis
Author
Year
Country
Sex (M/F)
Age
Surgery
ASA grade
Outcomes
Propofol group
Sevoflurane group
Method
No.
Method
No.
Yu et al.
2012
China
44 /36
68.8 ± 3.8
Lung cancer operation
I~II
①②③④⑤⑥
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: propofol
40
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: sevoflurane
40
Tang et al.
2014
China
38 /32
70.0 ± 11.7
Lung cancer operation
I~II
①②③④⑤⑥
Induction: etomidate, midazolam, fentanyl, rocuronium;
Maintain: propofol
35
Induction: etomidate, midazolam, fentanyl, rocuronium;
Maintain: sevoflurane
35
Sun et al.
2014
China
77 /29
72.2 ± 2.6
Lung cancer operation
N
①②③④⑤⑥
Induction: fentanyl and vecuronium bromide;
Maintain: propofol 2~4 mg/kg/min
53
Induction: fentanyl and vecuronium bromide;
Maintain: sevoflurane
53
Cui et al.
2015
China
94 /76
69 ± 12.9
Lung cancer operation
N
①③⑤⑥
Induction: fentanyl, etomidate, vecuronium bromide;
Maintain: propofol 2~4 mg/kg/min
80
Induction: fentanyl, etomidate, vecuronium bromide;
Maintain: sevoflurane 1%~ 3%
80
Zhang et al.
2016
China
101 /91
60.0 ± 6.4
Lung cancer operation
N
①③④⑥
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: propofol
96
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: sevoflurane
96
Wang H et al.
2015
China
41 /31
73.5 ± 2.8
Lung cancer operation
I~II
①②③④⑤⑥
Induction: unified rapid induction;
Maintain: propofol
36
Induction: unified rapid induction;
Maintain: sevoflurane
36
Wang F et al.
2017
China
32 /18
72.5 ± 3.0
Lung cancer operation
N
①②③④⑤⑥
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: propofol
50
Induction: midazolam, fentanyl, rocuronium, etomidate;
Maintain: sevoflurane
50
Zhao et al.
2014
China
80 /30
73.5 ± 2.0
Lung cancer operation
I~II
①②③④⑤⑥
Induction: fentanyl and vecuronium bromide;
Maintain: propofol 2~4 mg/kg/min
50
Induction: fentanyl and vecuronium bromide;
Maintain: sevoflurane
60
Chen et al.
2015
China
43 /35
69.2 ± 3.2
Lung cancer operation
N
①②③④⑤⑥
Induction: midazolam, propofol, fentanyl and vecuronium bromide;
Maintain: propofol 6~10 mg/kg/min
39
Induction: midazolam, propofol, fentanyl and vecuronium bromide;
Maintain: sevoflurane
39
Huang et al.
2015
China
50 /40
68.2 ± 1.3
Lung cancer operation
N
①②③④⑤⑥
Induction: rocuronium, fentanyl, midazolam, etomidate;
Maintain: propofol
45
Induction: rocuronium, fentanyl, midazolam, etomidate;
Maintain: sevoflurane
45
Lin et al.
2017
China
54/40
68.23 ± 1.32
Lung cancer operation
I~II
①②③④⑥
Induction: propofol, midazolam, vecuronium, fentanyl;
Maintain: propofol
40
Induction: propofol, midazolam, vecuronium, fentanyl;
Maintain: sevoflurane
54
Zhang et al.
2017
China
41/29
P: 74.8 ± 2.1; S: 74.3 ± 2.5
Lung cancer operation
I~II
②③④
Induction: fentanyl, etomidate, midazolam, rocuronium;
Maintain: propofol
35
Induction: fentanyl, etomidate, midazolam, rocuronium;
Maintain: sevoflurane
35
Yang et al.
2017
China
84/36
71.9 ± 2.5
Lung cancer operation
N
①②③④⑤⑥
Induction: unified rapid induction;
Maintain: propofol
60
Induction: unified rapid induction;
Maintain: sevoflurane
60
Tian et al.
2017
China
38/24
P: 68.3 ± 13.5; S: 65.5 ± 16.2
Lung cancer operation
I~II
①③⑥
Induction: midazolam, fentanyl, propofol;
Maintain: propofol
31
Induction: midazolam, fentanyl, sevoflurane;
Maintain: propofol
31
N Not mentioned, ASA American society of anesthesiology, ① = Preoperative MMSE score, ② = MMSE score at 6 h after surgery, ③ = MMSE score at 1 day after surgery, ④ = MMSE score at 3 day after surgery, ⑤ = MMSE score at 7 day after surgery, ⑥ = Plasma S100β protein level at 1 day after surgery, P Propofol, S Sevoflurane
Quality Evaluation: The Cochrane System Evaluation Criteria was used for this evaluation. We used the Cochrane Risk Bias Assessment Tool to analyze the literature bias [11].

Patient involvement

There was no patient involvement in the design and implementation of this study.

Statistical analysis

The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is serum S100beta concentration 24 h after surgery. STATA 13.0 (StataCorp LP, College Station, TX, USA) software was used for statistical analysis. In order to eliminate the influence of different units and differences in the means among different research studies, we analyzed the standard mean difference (SMD) and its 95% CI. We used the Galbr plot, I2 test and Cochran’s Q-test to determine whether the results are heterogeneous, and at the same time, we analyzed the heterogeneity by calculating I2. If the P value> 0.1 and I2 < 50%, the heterogeneity between the results is not apparent, so that a fixed effect model would be used for this meta-analysis; when P ≤ 0.1 and I2 ≥ 50%, it indicates that the results of the studies are heterogeneous. If the heterogeneity is apparent, then it could be eliminated by searching for the source of heterogeneity and analyzing the sensitivity; if the source of heterogeneity is not bright, the meta-analysis would be performed using a random-effect model. A bias risk assessment tool was used to assess the risk of bias. Detailed explanations of the mentioned analyses were included in Table 3. Two-tailed P values less than 0.05 were considered as statistically significant.
Table 3
The statistical methods used in this meta-analysis and their explanation
Goals and Usages
Statistic Methods
Explanations and Instructions
To evaluate heterogeneity between the included studies
Galbr plot
In Galbr figure, if the points all fall within the area between the upper line and the lower line, it can be taken as an evidence of homogeneity; otherwise, there is heterogeneity.
Cochran’s Q test
Cochran’s Q test is an extension to the McNemar test for related samples that provides a method for testing for differences between three or more matched sets of frequencies or proportions. Heterogeneity was also considered significant if P < 0.05 using the Cochran’s Q test.
I2 index test
The I2 index measures the extent of true heterogeneity dividing the difference between the result of the Q test and its degrees of freedom (k – 1) by the Q value itself, and multiplied by 100. I2 values of 25, 50 and 75% were used as evidence of low, moderate and high heterogeneity, respectively.
To examine the stability of the pooled results
Sensitivity analysis
A sensitivity analysis was performed using the one-at-a-time method, which involved omitting one study at a time and repeating the meta-analysis. If the omission of one study significantly changed the result, it implied that the result was sensitive to the studies included.
Publication bias test
Contour-enhanced funnel plot
Visual inspection of the Contour-enhanced funnel plots was used to assess potential publication bias. Asymmetry in the plots, which may be due to studies missing on the left-hand side of the plot that represents low statistical significance, suggested publication bias. If studies were missing in the high statistical significance areas (on the right-hand side of the plot), the funnel asymmetry was not considered to be due to publication bias

Results

Search results

The flowchart summarizing the study selection process following the PRISMA statement was reported in Fig. 1. A total of 1626 studies were identified in the initial search, including 108 studies from PubMed, 1131 studies from EMBASE, 148 studies from Cochrane Library, 195 studies from Web of Science, 44 studies from CNKI, and one academic meeting abstracts (Table 4). After screening based on inclusion and exclusion criteria, 372 articles were retrieved as eligible and then reviewed by two independent reviewers. Finally, fourteen studies, including 1404 patients, were included in the final meta-analysis [1225].
Table 4
Searching strategies and results for different databases (cut-off date: April 20, 2017)
Database
Database URL
Search strategy
Results
Pubmed
(“sevoflurane” [Supplementary Concept] OR “sevoflurane” [All Fields]) AND (“propofol” [MeSH Terms] OR “propofol” [All Fields]) AND (“lung” [MeSH Terms] OR “lung” [All Fields])
108
Embase
(‘sevoflurane’/exp. OR sevoflurane) AND (‘propofol’/exp. OR propofol) AND (‘lung’/exp. OR lung)
1131
Cochrane Library
Sevoflurane AND Propofol AND lung:ti, ab, kw
148
Web of Science
TOPIC: (Sevoflurane AND Propofol AND postoperative AND pain); Timespan: All years.
Indexes: SCI-EXPANDED, SSCI, A&HCI, ESCI.
195
CNKI
Search conditions: (topic = sevoflurane propofol lung cancer) (fuzzy matching), album navigation: all; database: literature cross-database search; search method: cross-database search
Database: Literature
44
Searching results and information of relevant academic meeting abstracts
Year
City
Meeting name
Article title
Whether included
2015
Beijing, P.R. China
Chinese seminar on translational medicine and integrative medicine
Difference of postoperative cognitive functions under propofol or sevoflurane anesthesia for lung cancer surgery
No

Patient characteristics

In terms of patient race group, all studies were performed in patients of Asian backgrounds. There was one study published in English and 13 studies in Chinese. The characteristics of the studies included in this meta-analysis were listed in Table 2 in detail.

Meta-analysis results and bias assessment results

The main results, including heterogeneity tests, effect models adopted accordingly, and the pooled SMDs with their 95% CI and the P value of this meta-analysis were presented in Table 5. The Galbr plots for the association between the use of narcotic drugs and postoperative cognitive function were shown in Fig. 2, suggesting that there was no heterogeneity only among the 10 studies [12, 13, 15, 17, 1922, 24, 25] with continuous data focusing on MMSE scores 7 days after the surgery, but not among other comparisons. Using fixed-effects model, the pooled SMD for the 10 studies was − 0.422 (95% CI: − 0.549, − 0.295, Z = 6.52; P < 0.001), the pooled WMD was − 0.371 (95% CI: − 0.493, − 0.249, P < 0.001), indicating that in terms of MMSE scores 7 days postoperatively, propofol has a greater adverse effect on cognitive function in the elderly patients with lung cancer than sevoflurane. The pooled SMD or WMD in issues of preoperative MMSE scores suggested no statistical difference (SMD -0.038, 95% CI: − 0.274, 0.198; WMD − 0.040, 95% CI: − 0.288, 0.208; Z = 0.31; P = 0.753). Then the pooled SMD in issues of postoperative MMSE scores at different time points were calculated using the random-effects model (except the MMSE score-7d). There were significant differences in issues of MMSE 6 h (11 studies; SMD -1.391, 95% CI -2.024, − 0.757; WMD -1.922, 95% CI -2.571, − 1.274; p < 0.001), MMSE 24 h (14 studies; SMD -1.106, 95% CI -1.588, − 0.624; WMD -1.504, 95% CI -2.253, − 0.755; p < 0.001), MMSE 3d (11 studies; SMD -1.065, 95% CI -1.564, − 0.566; WMD -1.376, 95% CI -2.044, − 0.708; p < 0.001), MMSE 7d (10 studies; SMD -0.422, 95% CI -0.549, − 0.295; WMD -0.371, 95% CI -0.493, − 0.249; p < 0.001), and the serum S100beta concentration at 1 day after surgery (13 studies; SMD 0.746, 95% CI 0.475, 1.017; WMD 0.018, 95% CI 0.016, 0.020; p < 0.001) (Fig. 3). We assessed the risk of bias using the Cochrane risk of bias tool [11]. Table 6 reported detailed results from the risk of a bias assessment tool.
Table 5
The results of the meta-analysis for the effect of propofol and sevoflurane on postoperative cognitive function
Comparative items
Data type
Heterogeneity test
Test of Association
Publication bias
MMSE and protein marker
Items
Q value
d.f.
I-squared
Tau-squared
P Value
Heterogeneity
Effect model
Pooled WMD
WMD 95% CI
Pooled SMD
SMD
95% CI
Z value
P value
Statistical significance
Preoperative cognitive function
Preoperative MMSE
Continuous
55.09
12
78.2%
0.1449
0.000
Yes
Random
-0.040
[−0.288, 0.208]
− 0.038
[− 0.274, 0.198]
0.31
0.753
No
No
Postoperative cognitive function evaluation
MMSE 6 h
Continuous
199.17
10
95.0%
1.0826
0.000
Yes
Random
−1.922
[−2.571, − 1.274]
−1.391
[− 2.024, −0.757]
4.30
0.000
Yes
No
MMSE 24 h
Continuous
216.54
13
94.0%
0.7859
0.000
Yes
Random
−1.504
[−2.253, −0.755]
− 1.106
[− 1.588, − 0.624]
4.50
0.000
Yes
No
MMSE 3d
Continuous
140.36
10
92.9%
0.6585
0.000
Yes
Random
−1.376
[−2.044, −0.708]
− 1.065
[− 1.564, − 0.566]
4.19
0.000
Yes
No
MMSE 7d
Continuous
16.75
9
46.3%
NA
0.053
No
fixed
−0.371
[−0.493, − 0.249]
−0.422
[− 0.549, − 0.295]
6.52
0.000
Yes
No
Protein marker S100β
S100β 1d
Continuous
67.94
12
82.3%
0.2024
0.000
Yes
Random
0.018
[0.016, 0.020]
0.746
[0.475, 1.017]
5.39
0.000
Yes
No
Table 6
Study quality: review authors’ judgments about each risk of bias item for each included study
Author
Year
Random sequence generation
Allocation concealment
Blinding of participants and personnel
Blinding of outcome assessment
Incomplete outcome data
Selective reporting
Other sources of bias
Yu et al.
2012
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Tang et al.
2014
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Sun et al.
2014
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Cui et al.
2015
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Zhang et al.
2016
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Wang H et al.
2015
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Wang F et al.
2017
Random number table
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Zhao et al.
2014
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Chen et al.
2015
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Low risk
Unclear risk
Huang et al.
2015
Random number table
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Lin et al.
2017
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Zhang et al.
2017
Unclear risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Unclear risk
Unclear risk
Yang et al.
2017
Low risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Low risk
Unclear risk
Tian et al.
2017
Low risk
Unclear risk
Unclear risk
Unclear risk
Low risk
Low risk
Unclear risk

Sensitivity analysis

To assess if a single study could affect the final SMDs, each study was removed one time, and the data re-pooled. The analysis results demonstrated that the pooled SMDs were not affected by deleting every single study. Figure 4 showed sensitivity analysis results in issues of postoperative pain and propofol/remifentanil use.

Publication bias

The contour-enhanced funnel plots (this term’s explanation could be seen in Table 3) were adopted to estimate potential publication biases, showing that most of the studies had missing areas for low statistical significance (the left-hand side of the plot), indicating no publication bias in present studies (Fig. 5).

Discussion

The potential risk for cognitive impairment following surgery and anesthesia is a common concern, especially in the elderly and more fragile patients. The risk for various neurocognitive effects is thus an area of importance. The independent impact of surgery and anesthesia is still not known. Likewise, the independent effect of different drugs used during anesthesia is a matter of debate, as is the number and amounts of drugs used and the “depth of anesthesia.” So, understanding the drug-related phenomenon and mechanisms for postoperative cognitive impairment is essential. This meta-analysis aims to compare the effects of propofol and sevoflurane anesthesia on postoperative cognitive function in elderly patients with lung cancer. This meta-analysis compared the effects of propofol and sevoflurane anesthesia on postoperative cognitive function in elderly patients (> 60-year-old) with lung cancer. Results suggested that propofol has a more significant adverse effect on cognitive function in elderly patients with lung cancer than sevoflurane. There were significant differences in issues of MMSE 6 h, MMSE 24 h, MMSE 3d, MMSE 7d, and the serum S100beta concentration at 1 day after surgery (all p < 0.01). Regarding the two drugs analyzed, the half-life of elimination of propofol has been estimated to be between 2 and 24 h. However, its duration of clinical effect is much shorter, because propofol is rapidly distributed into peripheral tissues. When used for IV sedation, a single dose of propofol typically wears off within minutes. The half-life of elimination of sevoflurane is 15–23 h.
At present, there is no uniform standard for the assessment of cognitive dysfunction in the world, and the most commonly used standard clinically is the MMSE score [26]. Studies found that the sensitivity and specificity of the MMSE method for assessing cognitive brain function were 87 and 82%, respectively [27]. The MMSE method is feasible and straightforward and is widely used for the screening of clinical cognitive dysfunction and cognitive decline [28]. The results of this meta-analysis showed that the MMSE scores at 6 h, 1d, 3d, and 7d after intravenous propofol anesthesia were significantly lower than those of sevoflurane. The reason may be that the sevoflurane has a shorter action time and is eliminated quickly. Laboratory data also showed that rats pretreated with high concentrations of sevoflurane could be effectively protected from focal cerebral ischemia, thus reducing neurological deficit scores, the volume of cerebral infarction, and cerebral edema areas. The incidence of post-cognitive disorders is adversely associated with higher concentrations of sevoflurane as a potential protective factor in non-cardiovascular procedures [29]. Experimental data have demonstrated that it may be because of the up-regulation of the expression levels of NR1 and NR2 subunits of hippocampal N-methyl-D-aspartate receptors that sevoflurane has a slighter effect on cognitive function in the elderly patients than propofol [30].
On a contour-enhanced funnel plot, contours of statistical significance are overlaid on the funnel plot. Adding contours of statistical significance facilitates the assessment of whether the areas where studies exist are areas of statistical significance and whether the areas where studies are potentially missing correspond to areas of low statistical significance. Generally, if studies appear to be missing in areas of low statistical significance, then it is possible that the asymmetry is due to publication bias. Conversely, studies perceived to be missing areas of high statistical significance likely do not suffer from publication bias as a source of funnel asymmetry. In the present meta-analysis, the funnel plot indicated no publication bias.
This meta-analysis has a few limitations. Firstly, we included only 14 articles. Although all these studies were conducted with propofol anesthesia and sevoflurane anesthesia as the experimental group and the control group, respectively, the doses of the drugs used for the elderly patients with lung cancer, the length of the operation time, and the use of adjuvant drugs were not the same. So, the problem of generalizability might exist. Secondly, most literature tends to report positive outcomes, while the studies with negative results are often not reported. Though not suggested via contour-enhanced funnel plots, the possibility of potential publication bias in included studies should not be overlooked. Thirdly, we did not perform a grey literature search, which might cause overestimations of effect sizes. Grey literature stands for manifold document types produced on all levels of government, academics, business and industry in print and electronic formats that are protected by intellectual property rights, of sufficient quality to be collected and preserved by libraries and institutional repositories, but not controlled by commercial publishers; i.e. where publishing is not the primary activity of the producing body. Fourthly, there are several tools more extensive tools available for assessment of recovery; however, in the present study, we only adopted MMSE as the outcome because of the data availability (MMSE is the most commonly used for screening). Although one may argue that merely presenting repeated MMSE scores is not sufficient for assessment of cognitive capacity and discriminating differences between groups, we believe that at this present time, due to the data availability mentioned above, the MMSE could say something. Fifthly, most of the included studies did not report enough the details of each patient, so it is not easy to separate between emergence reaction within hours from emergence, early cognitive changes - delirium and more protracted changes. Additionally, the many included studies had a relatively low methodology quality, so more rigorous large-scale randomized controlled trials are needed. Sixthly, the vast majority of the studies were conducted in China. The inter-racial variability of propofol anesthesia is well described. Therefore, it is not sure if the results are valid for other races. Seventhly, as is understood, co-administered drugs differed in included studies, but did any of the studies include regional anesthetic techniques? Could the greater peri-operative hypotension sometimes see with propofol have been a cause? Due to lacking these related data, the accuracy of the study’s conclusions will be questioned.

Conclusions

In summary, propofol has a more significant adverse effect on postoperative cognitive function in lung cancer patients than sevoflurane. In the included studies, some of the documents are of low quality and may affect the stability and reliability of the final results. Therefore, larger samples, more rigorous design, and higher quality tests are still needed for verification.

Acknowledgements

We thank our colleagues at the Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Because this is only a systematic review of previous retrospective studies and does not involve any human experiments or animal experiments, ethics approval and consent are not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Sheelakumari R, Kesavadas C, Lekha VS, Justus S, Sarma PS, Menon R. Structural correlates of mild cognitive impairment: a clinicovolumetric study. Neurol India. 2018;66(2):370–6.CrossRef Sheelakumari R, Kesavadas C, Lekha VS, Justus S, Sarma PS, Menon R. Structural correlates of mild cognitive impairment: a clinicovolumetric study. Neurol India. 2018;66(2):370–6.CrossRef
2.
Zurück zum Zitat Gupta A, Murthy P, Rao S. Brief screening for cognitive impairment in addictive disorders. Indian J Psychiatry. 2018;60(Suppl 4):S451–6.PubMedPubMedCentral Gupta A, Murthy P, Rao S. Brief screening for cognitive impairment in addictive disorders. Indian J Psychiatry. 2018;60(Suppl 4):S451–6.PubMedPubMedCentral
3.
Zurück zum Zitat Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139–44.CrossRef Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139–44.CrossRef
4.
Zurück zum Zitat Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008;108(1):18–30.CrossRef Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008;108(1):18–30.CrossRef
5.
Zurück zum Zitat Price CC, Garvan CW, Monk TG. Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology. 2008;108(1):8–17.CrossRef Price CC, Garvan CW, Monk TG. Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology. 2008;108(1):8–17.CrossRef
6.
Zurück zum Zitat Peng L, Xu L, Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis. PLoS One. 2013;8(11):e79624.CrossRef Peng L, Xu L, Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis. PLoS One. 2013;8(11):e79624.CrossRef
7.
Zurück zum Zitat Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International study of post-operative cognitive dysfunction. Lancet. 1998;351(9106):857–61.CrossRef Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International study of post-operative cognitive dysfunction. Lancet. 1998;351(9106):857–61.CrossRef
8.
Zurück zum Zitat Didkowska J, Wojciechowska U, Manczuk M, Lobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4(8):150.CrossRef Didkowska J, Wojciechowska U, Manczuk M, Lobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4(8):150.CrossRef
9.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.CrossRef
10.
Zurück zum Zitat Lim JA, Oh CS, Yoon TG, Lee JY, Lee SH, Yoo YB, Yang JH, Kim SH. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer. 2018;18(1):159.CrossRef Lim JA, Oh CS, Yoon TG, Lee JY, Lee SH, Yoo YB, Yang JH, Kim SH. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer. 2018;18(1):159.CrossRef
11.
Zurück zum Zitat Bertizzolo L, Bossuyt P, Atal I, Ravaud P, Dechartres A. Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design. BMJ Open. 2019;9(4):e028382.CrossRef Bertizzolo L, Bossuyt P, Atal I, Ravaud P, Dechartres A. Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design. BMJ Open. 2019;9(4):e028382.CrossRef
12.
Zurück zum Zitat Tang CJ, Xu SY. A comparative study for the influences on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Chin J Gerontol. 2014;34(13):3566–8. Tang CJ, Xu SY. A comparative study for the influences on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Chin J Gerontol. 2014;34(13):3566–8.
13.
Zurück zum Zitat Yang HW, Tian ZR, Zhang HB. Comparative study on influence of anesthesia with sevoflurane or Propofol on postoperative cognitive function in elder patients with lung Cancer. World Latest Med Inform. 2017;17(1):12–3. Yang HW, Tian ZR, Zhang HB. Comparative study on influence of anesthesia with sevoflurane or Propofol on postoperative cognitive function in elder patients with lung Cancer. World Latest Med Inform. 2017;17(1):12–3.
14.
Zurück zum Zitat Zhang W, Yang F. Comparison of the effects of seven sevoflurane and Propofol anesthesia on postoperative cognitive function in elderly patients with lung Cancer. China Contin Med Educ. 2017;9(26):69–70. Zhang W, Yang F. Comparison of the effects of seven sevoflurane and Propofol anesthesia on postoperative cognitive function in elderly patients with lung Cancer. China Contin Med Educ. 2017;9(26):69–70.
15.
Zurück zum Zitat Wang F, Sun HL. Effect of sevoflurane or Propofol anesthesia on the postoperative cognitive function of senile patients with lung Cancer. China Foreign Med Treat. 2017;36(12):131–3. Wang F, Sun HL. Effect of sevoflurane or Propofol anesthesia on the postoperative cognitive function of senile patients with lung Cancer. China Foreign Med Treat. 2017;36(12):131–3.
16.
Zurück zum Zitat Tian HT, Duan XH, Yang YF, Wang Y, Bai QL, Zhang X. Effects of propofol or sevoflurane anesthesia on the perioperative inflammatory response, pulmonary function and cognitive function in patients receiving lung cancer resection. Eur Rev Med Pharmacol Sci. 2017;21(23):5515–22.PubMed Tian HT, Duan XH, Yang YF, Wang Y, Bai QL, Zhang X. Effects of propofol or sevoflurane anesthesia on the perioperative inflammatory response, pulmonary function and cognitive function in patients receiving lung cancer resection. Eur Rev Med Pharmacol Sci. 2017;21(23):5515–22.PubMed
17.
Zurück zum Zitat Cui W. Effects of sevoflurane and propofol on the elderly patients with lung cancer. Healthy Living. 2015;14(8):28. Cui W. Effects of sevoflurane and propofol on the elderly patients with lung cancer. Healthy Living. 2015;14(8):28.
18.
Zurück zum Zitat Lin KX, Fang XK. Effects of sevoflurane and propofol on the elderly patients with lung cancer. Guide China Med. 2017;15(17):69–70. Lin KX, Fang XK. Effects of sevoflurane and propofol on the elderly patients with lung cancer. Guide China Med. 2017;15(17):69–70.
19.
Zurück zum Zitat Sun YC, Wang DT, Yu JH. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. China Prac Med. 2014;9(7):5–6. Sun YC, Wang DT, Yu JH. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. China Prac Med. 2014;9(7):5–6.
20.
Zurück zum Zitat Yu XC, Wang YG, Gao LB, Zhao HW. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. J Tianjin Med Univ. 2012;18(1):102–5. Yu XC, Wang YG, Gao LB, Zhao HW. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. J Tianjin Med Univ. 2012;18(1):102–5.
21.
Zurück zum Zitat Zhao LM, Wu LX, Yang BH, Xia YS. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. J Qiqihar Univ Med. 2014;35(21):3190–1. Zhao LM, Wu LX, Yang BH, Xia YS. Influence of anesthesia with sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. J Qiqihar Univ Med. 2014;35(21):3190–1.
22.
Zurück zum Zitat Chen ZQ. Influence on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Chin J Mod Drug Appl. 2015;9(15):167–8. Chen ZQ. Influence on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Chin J Mod Drug Appl. 2015;9(15):167–8.
23.
Zurück zum Zitat Zhang YH, Chen HM, Zhang Q, Han MQ. The influences of sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. Chin J of Clinical Rational Drug Use. 2016;9(5A):97–8. Zhang YH, Chen HM, Zhang Q, Han MQ. The influences of sevoflurane or propofol on postoperative cognitive function in elder patients of lung cancer. Chin J of Clinical Rational Drug Use. 2016;9(5A):97–8.
24.
Zurück zum Zitat Hung DH, Han Q, Liu CY. Influences of sevoflurane and propofol on the elderly patients with lung cancer. Chin J Gerontol. 2015;35(14):3961–3. Hung DH, Han Q, Liu CY. Influences of sevoflurane and propofol on the elderly patients with lung cancer. Chin J Gerontol. 2015;35(14):3961–3.
25.
Zurück zum Zitat Wang HT, Jiang HM. To compare the influences on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Inner Mongolia Med J. 2015;47(8):979–81. Wang HT, Jiang HM. To compare the influences on elderly patients with lung cancer anaesthetized with sevoflurane and propofol. Inner Mongolia Med J. 2015;47(8):979–81.
26.
Zurück zum Zitat Hemerka JN, Wu X, Dixon CE, Garman RH, Exo JL, Shellington DK, Blasiole B, Vagni VA, Janesko-Feldman K, Xu M, et al. Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice. J Neurotrauma. 2012;29(12):2192–208.CrossRef Hemerka JN, Wu X, Dixon CE, Garman RH, Exo JL, Shellington DK, Blasiole B, Vagni VA, Janesko-Feldman K, Xu M, et al. Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice. J Neurotrauma. 2012;29(12):2192–208.CrossRef
27.
Zurück zum Zitat Niwa H, Koumoto C, Shiga T, Takeuchi J, Mishima S, Segawa T, Atsumi T, Shimizu C, Koike T, Yoshioka N. Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT. Diabetes Res Clin Pract. 2006;72(2):142–7.CrossRef Niwa H, Koumoto C, Shiga T, Takeuchi J, Mishima S, Segawa T, Atsumi T, Shimizu C, Koike T, Yoshioka N. Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT. Diabetes Res Clin Pract. 2006;72(2):142–7.CrossRef
28.
Zurück zum Zitat Kong HY, Cheng DM, Pang W, Sun SD, Liu J, Huang CY, Jiang YG. Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City. J Nutr Health Aging. 2013;17(6):527–32.CrossRef Kong HY, Cheng DM, Pang W, Sun SD, Liu J, Huang CY, Jiang YG. Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City. J Nutr Health Aging. 2013;17(6):527–32.CrossRef
29.
Zurück zum Zitat Xu T, Bo L, Wang J, Zhao Z, Xu Z, Deng X, Zhu W. Risk factors for early postoperative cognitive dysfunction after non-coronary bypass surgery in Chinese population. J Cardiothorac Surg. 2013;8:204.CrossRef Xu T, Bo L, Wang J, Zhao Z, Xu Z, Deng X, Zhu W. Risk factors for early postoperative cognitive dysfunction after non-coronary bypass surgery in Chinese population. J Cardiothorac Surg. 2013;8:204.CrossRef
30.
Zurück zum Zitat Haseneder R, Starker L, Berkmann J, Kellermann K, Jungwirth B, Blobner M, Eder M, Kochs E, Rammes G. Sevoflurane anesthesia improves cognitive performance in mice, but does not influence in vitro long-term potentation in hippocampus CA1 stratum radiatum. PLoS One. 2013;8(5):e64732.CrossRef Haseneder R, Starker L, Berkmann J, Kellermann K, Jungwirth B, Blobner M, Eder M, Kochs E, Rammes G. Sevoflurane anesthesia improves cognitive performance in mice, but does not influence in vitro long-term potentation in hippocampus CA1 stratum radiatum. PLoS One. 2013;8(5):e64732.CrossRef
Metadaten
Titel
A systematic review: comparative analysis of the effects of propofol and sevoflurane on postoperative cognitive function in elderly patients with lung cancer
verfasst von
Haitao Sun
Guohua Zhang
Bolun Ai
Huimin Zhang
Xiangyi Kong
Wan-Ting Lee
Hui Zheng
Tao Yan
Li Sun
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2019
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-6426-2

Weitere Artikel der Ausgabe 1/2019

BMC Cancer 1/2019 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.